NO860458L - Antihypertensive dihydropyridinderivater. - Google Patents

Antihypertensive dihydropyridinderivater.

Info

Publication number
NO860458L
NO860458L NO860458A NO860458A NO860458L NO 860458 L NO860458 L NO 860458L NO 860458 A NO860458 A NO 860458A NO 860458 A NO860458 A NO 860458A NO 860458 L NO860458 L NO 860458L
Authority
NO
Norway
Prior art keywords
dimethyl
formula
compound
dihydropyridine
integer
Prior art date
Application number
NO860458A
Other languages
English (en)
Norwegian (no)
Inventor
Robin Douglas Clark
Moysey Michael Povzhitkov
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/700,439 external-priority patent/US4595690A/en
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO860458L publication Critical patent/NO860458L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20—Free hydroxyl or mercaptan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO860458A 1985-02-11 1986-02-10 Antihypertensive dihydropyridinderivater. NO860458L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/700,439 US4595690A (en) 1985-02-11 1985-02-11 Antihypertensive dihydropyridine derivatives
US06/808,401 US4672071A (en) 1985-02-11 1985-12-12 Antihypertensive dihydropyridine compositions, optical isomers and intermediates

Publications (1)

Publication Number Publication Date
NO860458L true NO860458L (no) 1986-08-12

Family

ID=27106619

Family Applications (1)

Application Number Title Priority Date Filing Date
NO860458A NO860458L (no) 1985-02-11 1986-02-10 Antihypertensive dihydropyridinderivater.

Country Status (15)

Country Link
US (1) US4672071A (da)
EP (1) EP0191448A3 (da)
JP (1) JPS61210071A (da)
KR (1) KR860006442A (da)
AU (1) AU591093B2 (da)
DK (1) DK64286A (da)
ES (2) ES8708130A1 (da)
FI (1) FI860584A7 (da)
GR (1) GR860384B (da)
HU (2) HU198478B (da)
IL (1) IL77843A (da)
NO (1) NO860458L (da)
PH (1) PH22806A (da)
PL (1) PL257890A1 (da)
PT (1) PT81987B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2576843A (en) * 1944-12-30 1951-11-27 Rosenblads Patenter Ab Heat exchange apparatus
US2788065A (en) * 1950-08-14 1957-04-09 Rosenblads Patenter Ab Surface type evaporator employing channel switching for cleaning purposes
US4814455A (en) * 1986-04-16 1989-03-21 Bristol-Myers Company Dihydro-3,5-dicarboxylates
JPH0686429B2 (ja) * 1986-08-27 1994-11-02 株式会社ミドリ十字 ジヒドロピリジン誘導体
US4886819A (en) * 1986-08-27 1989-12-12 The Green Cross Corporation Dihydropyridine derivatives and pharmaceutical composition thereof
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
US5576439A (en) * 1994-10-28 1996-11-19 Ciba-Geigy Corporation Dihydropyridinecarboxylic acid anhydrides
SE9801990D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031104A (en) * 1972-04-18 1977-06-21 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
CH583702A5 (en) * 1973-02-13 1977-01-14 Science Union & Cie Anti-hypertensive dihydropyridines - 4-aryl 2,5-dihydropyridine 3,5-dicarboxylic esters
US3985758A (en) * 1973-02-20 1976-10-12 Yamanouchi Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4154839A (en) * 1975-11-05 1979-05-15 Bayer Aktiengesellschaft 2,6-Dimethyl-3-carboxymethoxy-4-(2-nitrophenyl)-5-carbisobutoxy-1,4-dihydropyridine
DE2639498A1 (de) * 1976-09-02 1978-03-09 Bayer Ag Neue schwefelhaltige amino-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
US4595690A (en) * 1985-02-11 1986-06-17 Syntex (U.S.A.) Inc. Antihypertensive dihydropyridine derivatives
GB8503426D0 (en) * 1985-02-11 1985-03-13 Ici Plc Pyridine derivatives

Also Published As

Publication number Publication date
IL77843A (en) 1989-07-31
HU198019B (en) 1989-07-28
FI860584A7 (fi) 1986-08-12
PH22806A (en) 1988-12-27
JPS61210071A (ja) 1986-09-18
DK64286A (da) 1986-08-12
HU198478B (en) 1989-10-30
HUT44501A (en) 1988-03-28
ES551809A0 (es) 1987-10-16
ES8708130A1 (es) 1987-10-16
EP0191448A3 (en) 1987-08-19
ES557628A0 (es) 1988-07-01
US4672071A (en) 1987-06-09
KR860006442A (ko) 1986-09-11
GR860384B (en) 1986-05-09
FI860584A0 (fi) 1986-02-10
AU5336386A (en) 1986-08-14
PT81987B (en) 1987-08-13
PL257890A1 (en) 1988-07-21
DK64286D0 (da) 1986-02-10
EP0191448A2 (en) 1986-08-20
HUT41732A (en) 1987-05-28
AU591093B2 (en) 1989-11-30
PT81987A (en) 1986-03-01
ES8802449A1 (es) 1988-07-01

Similar Documents

Publication Publication Date Title
SU932988A3 (ru) Способ получени оптически активных производных 1,4-дигидропиридинкарбоновой кислоты
DK166725B1 (da) 5-arylalkyl-4-alkoxy-2(5h)-furanoner, fremgangsmaader til deres fremstilling og laegemidler indeholdende disse forbindelser
US4470989A (en) Neuroleptic n-oxacyclyl-alkylpiperidine derivatives
US5082847A (en) Carbostyril compounds connected via an oxyalkyl group with a piperidine ring and having pharmaceutical utility
CZ397598A3 (cs) Derivát 5-fenoxyalkyl-2,4-thiazolidindionu, způsob jeho přípravy, meziprodukty pro jeho přípravu a farmaceutický prostředek, který ho obsahuje
JPH0581588B2 (da)
EP0296316A1 (de) 1,4-Dihydropyridin-Enantiomere
NO860458L (no) Antihypertensive dihydropyridinderivater.
US4680310A (en) Tetrahydronaphthalene derivatives
CH651040A5 (fr) Procedes de preparation de trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido(4,3-b)-indoles substitues en position 2 dextrogyres et medicament les contenant.
EP0171702A1 (en) Benzoxazinone derivatives, preparation and use
US4761420A (en) Antihypertensive dihydropyridine derivatives
HUT54346A (en) Process for producing new, antiarrhythmic, sulfur-containing cyanophenol derivatives and medical compositions comprising same
EP0147847B1 (en) Optically active compounds with antitussive and central sedative activity, a process for the preparation thereof and compositions containing the same
EP0140359B1 (en) Morpholine derivatives
US4595690A (en) Antihypertensive dihydropyridine derivatives
EP0360685A1 (fr) "[(diarylméthoxy) alcoyl] - 1 pyrrolidines et piperidines, procédés de préparation et médicaments les contenant"
EP0458697A1 (fr) Trifluorométhylphényltétrahydropyridines N-substituées, procédé pour leur préparation, intermédiaires du procédé et compositions pharmaceutiques les contenant
NO167029B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinkarboksylsyrederivater
NO309649B1 (no) <alfa>-(substituerte alkylfenyl)-4-(hydroxydifenylmethyl)-1- piperidinbutanolderivater og deres anvendelse til fremstilling av antihistaminer, anti-allergimidler og bronchodilatorer
JPS604177B2 (ja) ベンゾフラン誘導体の製造方法
JPS6341460A (ja) 新規なジヒドロピリジン誘導体
EP0142102B1 (en) Tertiary amines
Baltzly et al. Amines Related to 2, 5-Dimethoxyphenethylamine. 1 I
JP2744224B2 (ja) ビス−アザ−二環式抗不安薬の製法